In other studies, the immunohistochemical staining of RAC1 showed weak RAC1 expression in benign breast disease but high expression level in ductal carcinoma-in-situ, primary breast cancer, and lymph node metastases [10]. Here, RAC1 is linked to breast fibrocystic disease.